GH Research PLC (GHRS)
11.12
+0.37
(+3.44%)
USD |
NASDAQ |
Apr 30, 16:00
11.12
0.00 (0.00%)
After-Hours: 19:39
GH Research Cash from Operations (TTM): -33.34M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.34M |
| September 30, 2023 | -32.12M |
| June 30, 2023 | -29.82M |
| March 31, 2023 | -27.08M |
| December 31, 2022 | -26.20M |
| September 30, 2022 | -23.09M |
| June 30, 2022 | -24.26M |
| Date | Value |
|---|---|
| March 31, 2022 | -20.20M |
| December 31, 2021 | -15.28M |
| September 30, 2021 | -11.67M |
| June 30, 2021 | -2.538M |
| March 31, 2021 | -1.315M |
| December 31, 2020 | -0.33M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-33.34M
Minimum
Dec 2023
-0.33M
Maximum
Dec 2020
-19.02M
Average
-23.09M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Amarin Corp PLC | 6.88M |
| Jazz Pharmaceuticals PLC | 1.092B |
| Prothena Corp PLC | -133.91M |
| Iterum Therapeutics PLC | -39.33M |
| Mural Oncology PLC | -- |